FBXW7 mediates chemotherapeutic sensitivity and prognosis in NSCLCs.
Yokobori T, Yokoyama Y, Mogi A, Endoh H, Altan B, Kosaka T, Yamaki E, Yajima T, Tomizawa K, Azuma Y, Onozato R, Miyazaki T, Tanaka S, Kuwano H.
Yokobori T, et al. Among authors: tanaka s.
Mol Cancer Res. 2014 Jan;12(1):32-7. doi: 10.1158/1541-7786.MCR-13-0341. Epub 2013 Oct 28.
Mol Cancer Res. 2014.
PMID: 24165483
Free article.